Ensign Peak Advisors, Inc Harmony Biosciences Holdings, Inc. Transaction History
Ensign Peak Advisors, Inc
- $56.1 Billion
- Q3 2024
A detailed history of Ensign Peak Advisors, Inc transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Ensign Peak Advisors, Inc holds 13,385 shares of HRMY stock, worth $466,199. This represents 0.0% of its overall portfolio holdings.
Number of Shares
13,385
Previous 13,385
-0.0%
Holding current value
$466,199
Previous $403,000
32.51%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding HRMY
# of Institutions
243Shares Held
45.2MCall Options Held
108KPut Options Held
49.2K-
Valor Management LLC Chicago, IL11.2MShares$391 Million100.0% of portfolio
-
Black Rock Inc. New York, NY5.84MShares$203 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.47MShares$121 Million0.0% of portfolio
-
Vivo Capital, LLC Palo Alto, CA2.61MShares$90.8 Million15.24% of portfolio
-
Pacer Advisors, Inc. Malvern, PA1.93MShares$67.2 Million0.18% of portfolio
About Harmony Biosciences Holdings, Inc.
- Ticker HRMY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,161,400
- Market Cap $2.06B
- Description
- Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...